Clinical trial Recruiting at 7 sites Interventional Ages 18 and up

CRP point-of-care testing to guide antibiotic use for adults with respiratory symptoms in eight Jakarta primary care centers

Official title: Implementation of C-reactive Protein Point of Care Testing to Improve Antibiotic Use in Respiratory Tract Infection in the Indonesian Primary Health Care

Run by Oxford University Clinical Research Unit Indonesia · NCT07717372 · Data updated 2026-11-12

This trial tests whether using a C-reactive protein point-of-care test can help doctors in Jakarta decide when antibiotics are needed for adults with acute respiratory infections.

More Older Adults (65 Years and Older) trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment2544 (estimated)
SponsorOxford University Clinical Research Unit Indonesia
Academic / other
Locations8 sites (Jakarta and 7 other locations)
StatusRecruiting
StartedApril 6, 2026
Main results expectedOctober 2026
Study endsOctober 2026
Registry record updatedJuly 21, 2026
Trial IDNCT07717372 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 and older presenting with a new ARTI episode at participating primary health care centers and exhibiting relevant symptoms within the prior five days.

Probably not a fit

Patients with severe illness requiring referral, known immunosuppression or chronic conditions, or those who have already taken antibiotics for the current visit may derive less or no benefit from the CRP-guided approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study evaluates the implementation of C-reactive protein (CRP) point-of-care testing in eight primary health care centers in Jakarta to reduce unnecessary antibiotic prescriptions for acute respiratory tract infections (ARTI) without increasing clinical failures by day seven. The study uses a cluster design to compare the CRP-guided approach with standard care, enrolling about 2,544 adults across sites with a target of roughly 318 patients per center. The sample size and analysis account for intra-cluster correlation and a non-inferiority margin, aiming to preserve clinical outcomes while decreasing antibiotic exposure. The investigation builds on prior data from LMICs and seeks to adapt ICC assumptions to the Indonesian primary care context. Leading institutions include the Oxford University Clinical Research Unit Indonesia and collaborating hospitals and universities in Indonesia and Vietnam.

Why it matters

Potential benefit: If successful, CRP POCT could reduce unnecessary antibiotic prescriptions for ARTI and help combat antimicrobial resistance in primary care.

How similar studies have gone: Previous LMIC studies suggest CRP POCT can reduce antibiotic prescribing without compromising safety, though Indonesian data in this specific cluster implementation are limited and context-specific.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adults aged ≥18 years.
2. Presenting to the PHC site for the first consultation of the current episode of Acute-Respiratory Tract Infections (ARTI).
3. Reporting at least one of the following symptoms or clinical signs within the past 5 days: cough, rhinitis (e.g., sneezing, nasal congestion, or runny nose), pharyngitis (e.g., sore throat), shortness of breath, wheezing, chest pain, abnormal lung sounds on auscultation.

Exclusion Criteria:

1. Presenting with severe illness requiring referral to a higher-level healthcare facility (e.g., hospital).
2. Having known immunosuppression or chronic conditions, including but not limited to: HIV infection; chronic liver disease; history of malignancy; long-term use of systemic corticosteroids or other immunosuppressive therapies, as assessed by the healthcare worker or study team.
3. Having taken antibiotics prior to the visit to the primary health center.

Where it's running

  • Cengkareng Public Health Center
    Jakarta, Indonesia
    Recruiting
  • Pulo Gadung Public Health Center
    Jakarta, Indonesia
    Recruiting
  • Jatinegara Public Health Center
    Jakarta, Indonesia
    Recruiting
  • Duren Sawit Public Health Center
    Jakarta, Indonesia
    Recruiting
  • Cakung Public Health Center
    Jakarta, Indonesia
    Recruiting
  • Cilincing Public Health Center
    Jakarta, Indonesia
    Recruiting
Show 2 more locations
  • Koja Public Health Center
    Jakarta, Indonesia
    Recruiting
  • Kebayoran Lama Public Health Center
    Jakarta, Indonesia
    Enrolling by invitation

Study contacts

  • Principal investigator: Robert Sinto, MD, DPhil — Dr Cipto Mangunkusumo General Hospital
  • Study coordinator: Robert Sinto, MD, DPhil
  • Email: rsinto@oucru.org
  • Phone: +622123599099

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.